BioSpace News Archive

Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired Ireland -based Megazyme, Ltd. — a major supplier of analytical solutions used by quality control laboratories in the global food and beverage industries. Megazyme will continue to operate as a standalone business, and will be managed through Neogen’s European op

Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that as per a purchase order the Company received in late 2020, it has begun selling CompuFlo® disposables to the University of Texas Medical Branch at Galveston (UTMB), an institution of the University of Texas System and agency of the State of Texas. UTMB is a

Bioniz Therapeutics, Inc., (“Bioniz”), a clinical-stage biopharmaceutical company advancing a pipeline of first-in-class peptide-based multi-cytokine inhibitors for the treatment of cancer and autoimmune diseases, announced today that the U.S. Food and Drug Administration (FDA) provided positive feedback during the company’s end of Phase 2 (EOP2) meeting for Bioniz’s BNZ-1.

Wize Pharma , Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that, on December 29, 2020 , it has completed the transactions contemplated by the previously reported Addendum to a Share Purchase Agreement, dated November 29, 2020 (the “Addendum

Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping the first authorized generic versions of Mallinckrodt’s Amitiza ® (lubiprostone) 8 mcg and 24 mcg capsules. “This partnership brings the first Amitiza ® generic to patients—giving them a cost-e

PPD, Inc. (Nasdaq: PPD ), a leading global contract research organization, will present virtually at the 39th Annual J.P. Morgan Healthcare Conference. David Simmons, chairman and CEO, and Chris Scully, CFO, are scheduled to present on Monday, Jan. 11, 2021, at 2:50 p.m. (U.S. Eastern Time). A live and archived webcast of the presentation, along with accompanying slides, will be accessible for up to 30 days through

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced an update on the launch of a new global clinical trial for intravenous (“IV”) treatment of COVID-19 with Ampion and provided updates on its o

January 4, 2021 - BetterLife Pharma Inc., an emerging biotech company, is pleased to announce it has applied for patent protection of new 2-Bromo-LSD formulations and their use in the treatment of depression and mood disorders.

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided a supply update for the Moderna COVID-19 Vaccine, increasing its base-case global productio

Perspectum Announces American Medical Association Issues Unique Category III CPT ® Codes for Liver MultiScan ® Quantitative Multiparametric MR SAN FRANCISCO--( BUSINESS WIRE )-- The American Medical Association (AMA) has issued two new Current Procedural Terminology (CPT ® ) codes for Quantitative Multiparametric MR to report Liver MultiScan , which can help clinicians diagnose and treat patients with liver disease. This press release features multimedi